ASTANA, Kazakhstan, December 19. Kazakhstan and
Japan's Sumitomo Corporation discussed the preparation of a joint
project in the field of nuclear medicine and the implementation of
joint investment projects in transport and logistics, as well as
the energy sector, Trend reports via the press service of the Kazakh
President.
The issues were discussed during a meeting between Kassym-Jomart
Tokayev, President of Kazakhstan, and Shingo Ueno, Representative
Director, President, and CEO of Sumitomo Corporation.
Shingo Ueno highlighted that Sumitomo is actively engaged in a
project with Kazakhstan’s national company, Kazatomprom, focused on
developing scientifically grounded methods for producing medical
radioisotopes from uranium processing by-products.
President Tokayev underscored Kazakhstan’s deep appreciation for
Sumitomo’s commitment to sustainable growth and responsible
business practices, emphasizing the company’s role as a long-term
strategic partner.
Sumitomo Corporation is a global integrated trading and business
investment entity, with a vast network comprising 127 offices
across 64 countries and regions.
